Research prototype, not medical advice.

In the PLASMA phase I trial, young plasma infusion in Alzheimer was safe and feasible, with no proven efficacy (small sample).

Confidence
Speculative
Level of evidence
Randomized clinical trial
Observed in
Human
Mission
Map of aging (12 hallmarks)
Concepts
Altered intercellular communicationYoung plasma infusionAlzheimer's disease

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study
Sha et al. · JAMA Neurology 2019
— Verified

Related claims